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ABSTRACT 
Cell division is the process by which mother cells give rise to two genetically identical 
daughter cells. All cells have protein networks to ensure that cell division is completed 
correctly because mistakes during the cell division may cause diseases. The Anaphase-
promoting complex (APC) is an important regulatory enzyme that ensures successful 
completion of mitosis. It acts by removing inhibitors of chromosomal segregation and 
cytokinesis, as well as other important cell division regulators. Existing chemotherapies, like 
taxol, act by indirectly inhibiting APC function. This makes APC a potential target for new 
cancer chemotherapies. However, designing APC inhibitors is challenging because how APC 
interacts with its substrates is not fully understood. What is currently known is that APC 
recognizes a short linear sequence containing R-x-x-L, called the destruction box (D-box). A 
D-box is needed for efficient proteolysis of most APC substrates, but what makes a functional 
D-box is still unclear. The goal of my project is to define the minimal functional D-box using an 
artificial reporter substrate containing the known D-box motif from the budding yeast APC 
substrate Fin1. To accomplish this goal, reporter expression plasmids are mutated and the 
stability of the mutant proteins are measured and compared using a cycloheximide chase 
assay. Any mutation in the D-box will cause slower decay in the immunoblotting signal for the 
reporter substrate after protein synthesis is terminated. By defining the minimal functional D-
box, we can understand how APC interacts with its substrates, helping the development of 
chemotherapy drugs to kill cancer cells. 
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